"Physicians should be concerned about the increased risk of gallbladder or biliary disease associated with GLP-1 RA use, especially at the higher doses recommended for weight loss," the authors write
Blood pressure under 140/90, no history of gallbladder issues, kidney function within normal limits, and no active gastrointestinal conditions create a safer foundation for aggressive dosing
Do not take two doses to compensate for a missed one
Can these drops really replace exercise or a balanced diet
Personal Opinion The clinical data, while promising, comes from populations focused on weight loss rather than body composition optimization
Major insurers such as UnitedHealthcare, Blue Cross Blue Shield, Aetna, and others often cover these medications for qualifying patients, and Klinic handles the daunting task of prior authorization